Federal contract award
W81K0020P0376
TUBERCULOSIS TESTING, DEPARTMENT OF PATHOLOGY AND AREA LABORATORY SERVICES, BROOKE ARMY MEDICAL CENTER, JBSA FORT SAM HOUSTON, TEXAS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRC0 WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $617.7K |
| Current contract value | $1.4M |
| Potential contract value / ceiling | $1.4M |
| Start date | Oct 1, 2020 |
| Current end date | Sep 30, 2025 |
| Potential end date | Sep 30, 2025 |
| Latest award activity | May 15, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 15, 2025 | P00012 | $-372.4K | QUANTIFERON TB GOLD PLUS - DE-OBLIGATE FY23 FUNDS. |
| Feb 26, 2025 | P00011 | $-306.7K | QUANTIFERON TB GOLD PLUS - DE-OBLIGATION MODIFICATION |
| Dec 12, 2024 | P00010 | $442.5K | QUANTIFERON TB GOLD PLUS - FY25 FUNDING MODIFICATION. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.